Comparative Pharmacology
Head-to-head clinical analysis: LORATADINE AND PSEUDOEPHEDRINE SULFATE versus WYAMINE SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LORATADINE AND PSEUDOEPHEDRINE SULFATE versus WYAMINE SULFATE.
LORATADINE AND PSEUDOEPHEDRINE SULFATE vs WYAMINE SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Loratadine: Selective peripheral H1-receptor antagonist, reducing histamine-mediated allergic responses. Pseudoephedrine sulfate: Indirect sympathomimetic, releasing norepinephrine from presynaptic terminals, causing vasoconstriction and decongestion.
Wyamine sulfate (mephentermine sulfate) is a sympathomimetic amine that acts primarily by releasing norepinephrine from presynaptic nerve terminals, with direct alpha- and beta-adrenergic receptor agonist activity. It causes vasoconstriction and positive inotropic effects, increasing cardiac output and blood pressure.
One tablet (loratadine 5 mg/pseudoephedrine sulfate 120 mg) orally every 12 hours. Maximum: 2 tablets per day.
Intramuscular injection: 15-30 mg as a single dose; may repeat in 10-15 minutes if needed. Maximum total dose: 60 mg.
None Documented
None Documented
Loratadine: 8-14 hours (terminal); its active metabolite descarboethoxyloratadine: 17-24 hours. Pseudephedrine sulfate: 5-8 hours (dependent on urine pH; alkaline urine prolongs half-life).
Terminal elimination half-life is 6-8 hours in adults with normal renal function (CrCl >90 mL/min).
Loratadine and its metabolites are primarily excreted in urine (approximately 80%) and feces (approximately 20%). Pseudephedrine is predominantly excreted unchanged in urine (70-90%), with the remainder as inactive metabolites.
Primarily renal; 90% excreted unchanged in urine within 24 hours. Minimal biliary/fecal elimination (<5%).
Category A/B
Category C
Sympathomimetic
Sympathomimetic